H Scott Boswell
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib (NCT04079738) | H Scott Boswell | 2019-09-20 |
Track H Scott Boswell automatically
Every clearance here is in the API, with alerts when new ones post.